Net Loss Per Share Attributable to Common Stockholders (Tables)

6 Months Ended

Aug. 31, 2022

Net income (Loss) Per Share Attributable to Common Stockholders

Schedule of computation of basic and diluted net loss per share

	Three months ended				Six months ended
	August 31,				August 31,
	2022		2021		2022		2021
Net loss	$	(46,523)	$	(62,364)	$	(389,345)	$	(111,071)
Weighted-average common shares used in computing net loss per share		70,475,778		64,404,223		70,251,890		61,332,729
Net loss per share attributable to common stockholders, basic and diluted	$	(0.66)	$	(0.97)	$	(5.54)	$	(1.81)

Schedule of common stock were excluded from the computation of diluted net loss per share attributable to common stockholders

	Six months ended
	August 31,
	2022	2021
Stock options	8,590,272	8,685,132
Unvested restricted stock units	5,295,247	1,722,302
Shares issued to 2nd.MD employees and subject to vesting	274,224	608,332
Contingent shares in connection with 2nd.MD acquisition	—	1,889,441
Shares issued to PlushCare employees and subject to vesting	537,401	850,511
Contingent shares in connection with PlushCare acquisition	102,111	1,494,210
Indemnity shares held in escrow in connection with PlushCare acquisition	27,342	27,382
Shares to be issued to HealthReveal shareholders upon expiration of indemnification	28,089	—
Convertible Senior Notes	5,700,297	5,700,297
Total	20,554,983	20,977,607